ESC Professional Premium Access

Suboptimal Lipid Measurement and Statin Use after Percutaneous Coronary Intervention is associated with Increased Mortality: Results of a Real World Registry of 76,264 Patients in NW London

Congress Presentation

About the speaker

Doctor Majid Akhtar

Harefield Hospital, Royal Brompton and Harefield NHS Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)
2 presentations
1 follower

5 more presentations in this session

LDL-Cholesterol levels and lipid lowering therapy in secondary prevention patients: preliminary data from BRING-UP Prevention Study

Speaker: Professor A. Maggioni (Florence, IT)

Thumbnail

Intensive, early and sustained lowering of atherogenic lipoproteins after myocardial infarction and long-term prognosis: a nationwide cohort study of myocardial infarction patients

Speaker: Ms J. Schubert (Uppsala, SE)

Thumbnail

Association of early versus late use of combination lipid-lowering therapy with major cardiovascular outcomes after myocardial infarction: data from the SWEDEHEART registry

Speaker: Associate Professor M. Leosdottir (Malmo, SE)

Thumbnail

A global perspective of Lp(a) levels in patients with coronary heart disease - Implications for risk factor control & future trials from the INTERASPIRE Study

Speaker: Professor K. Ray (London, GB)

Thumbnail

Optimising oral lipid-lowering therapy regimens in high and very high-risk statin intolerant patients with dyslipidaemia: A French real-world simulation

Speaker: Professor F. Schiele (Besancon, FR)

Thumbnail

Access the full session

Registries, observational, and other studies on lipids

Speakers: Doctor M. Akhtar, Professor A. Maggioni, Ms J. Schubert, Associate Professor M. Leosdottir, Professor K. Ray...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations